3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
44
Liver Neoplasms
18
Colorectal Neoplasms
15
Neoplasm Metastasis
11
Cholangiocarcinoma
11
Pancreatic Neoplasms
9
Colonic Neoplasms
9
Barrett Esophagus
7
Rectal Neoplasms
6
Recurrence
5
Esophageal Neoplasms
4
Biliary Tract Neoplasms
3
Bile Duct Neoplasms
3
Hepatitis B
2
Gallbladder Neoplasms
2
Stomach Neoplasms
1
Solid Tumor Including Thyroid, Bone, Liver, Pancreas
1
Pancreatic cancer, adult
1
Pancreatic Neuroendocrine Tumors, WHO Grade I-II
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Neoplasms, Glandular and Epithelial
1
Neoplasms
1
Neoplasm Micrometastasis
1
Multi-organ Metastatic Colorectal Cancer
1
Liver Metastasis Colon Cancer
1
Klatskin Tumor
1
Jaundice, Obstructive
1
Hypertension, Portal
1
Hepatitis B, Chronic
1
Interventions
Propranolol
3
Portasystemic Shunt, Transjugular Intrahepatic
2
tremelimumab
1
durvalumab
1
Radiofrequency Ablation
1
Liver Transplantation
1
Hepatectomy
1
Diagnostic Imaging
1
Carvedilol
1
Bevacizumab
1
6-acetylaminocaproic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypertension, Portal
×
Radiofrequency Ablation
×
Gastrointestinal
×
Clear all
NCT02192671
2022-01-18
HR-HCC/PHT
Guangxi Medical University
Phase 3
Unknown
120 enrolled